SCHEMBL6773156

SCHEMBL6773156

CCC(C(=O)O)C(N)c1cc(OC(C)C)cc(OC(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 2/20 0.38
LNPEP Q9UIQ6 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
PARP10 Q53GL7 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NSD2 O96028 1/20 0.35
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35
PPARD Q03181 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778494 0.83 PTGS2 (0.48) RXRARXRBPARP10SMN1; SMN2PPARG
Hydrochloric Acid SCHEMBL6776920 0.82 PTGS2 (0.47) RXRARXRBPARP10SMN1; SMN2PPARG
SCHEMBL6778049 0.79 FABP3 (0.43) RXRARXRB
Hydrochloric Acid SCHEMBL6378952 0.74 TPMT (0.39) KMT2AALDH1A1RXRARXRBSMN1; SMN2
SCHEMBL7356667 0.74 SLC1A1 (0.39)
Hydrochloric Acid SCHEMBL6378948 0.74 TPMT (0.39) KMT2AALDH1A1RXRARXRBSMN1; SMN2
Hydrochloric Acid SCHEMBL6779507 0.73 TPMT (0.38) KMT2ARXRARXRB
SCHEMBL6780474 0.72 TTR (0.43) ALDH1A1PPARG
SCHEMBL6779107 0.72 TTR (0.43) KMT2AALDH1A1SMN1; SMN2
SCHEMBL2298439 0.72 DPP4 (0.48) KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6831199-B1 In order to avoid bleeding side-effects when treating the conditions associated with integrin alpha v beta 3, it is beneficial to have compounds which are selective antagonists for alpha v beta 3 versus alpha IIb beta 3 G. D. SEARLE & CO. 2004-12-14 US disclosed